Assessment of trazodone-induced cardiotoxicity after repeated doses in rats. (January 2019)

• Record Type: Journal Article
• Authors: Atli, O; Kilic, V; Baysal, M; Kilic, G; Gormus, G; Ucarcan, S; Korkut, B; Ilgin, S
• Is Part Of: Human & experimental toxicology. Volume 38:Number 1(2019)
• Page Start: 45
• Page End: 55
• Publication Date: 2019-01
• Subjects: Trazodone -- cardiotoxicity -- cardiac biomarkers -- ECG -- DNA damage -- oxidative stress; Toxicology -- Periodicals; 615.9
• DOI: 10.1177/0960327118769717
• Languages: English
• ISSNs: 0960-3271

Abstract

Trazodone (TRZ) is an antidepressant drug commonly used in the treatment of depression, anxiety, and insomnia. Although some studies demonstrated the adverse effects of TRZ related to cardiovascular system, the conflicting results were observed in these studies. Therefore, we aimed to investigate the cardiac adverse effects of TRZ in rats at repeated doses in our study. In accordance with this purpose, TRZ was administered orally to rats at 5, 10, and 20 mg/kg doses for 28 days. Electrocardiogram records, serum aspartate aminotransferase (AST), lactate dehydrogenase, creatine kinase-myoglobin band, cardiac troponin-T (cTn-T) levels, DNA damage in cardiomyocytes, and histologic view of heart tissues were evaluated. In addition, glutathione (GSH) and malondialdehyde (MDA) levels were measured to determine the oxidative status of cardiac tissue after TRZ administration. Heart rate was decreased, PR interval was prolonged, and QRS and T amplitudes were decreased in 20 mg/kg TRZ-administered group compared to the control group. Serum AST and cTn-T levels were significantly increased in 10 and 20 mg/kg TRZ-administered rats with respect to control rats. DNA damage was significantly increased in these groups. Additionally, degenerative histopathologic findings were observed in TRZ-administered groups. Although there was no difference in MDA levels between groups, GSH levels were significantly decreased in 10 and 20 mg/kg TRZ-administered groups compared to the control group. Our results have shown that TRZ induced cardiotoxicity in rats dose-dependently. It is assumed that oxidative stress related to GSH depletion may be accompanied by these adverse effects.